Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


Preimplantation Genetic Diagnosis: The Who, the What, the Why and the How


 

Brain tissue transplants not effective for treating Huntington's

02 August 2009

By Rosie Beauchamp

Appeared in BioNews 519

A paper published in the 'Proceedings of the National Academy of Sciences' has outlined disappointing conclusions surrounding the use of brain tissue transplants to treat Huntington's disease. Thomas Freedman and colleagues at the University of South Florida in Tampa, US, report that transplanting portions of fetal brain tissue is not as successful as was previously believed.

Huntington's disease is an inherited genetic disorder which causes the production of mutant huntingtin protein in the patient's brain. The build up of this mutant protein in turn leads to the loss of neurons in different parts of the brain, most significantly in the striatum. The subsequent degeneration of the brain causes defects in movement and cognitive behaviour in the patient, and is ultimately fatal.

The use of neural transplants has been used as an experimental treatment for Huntington's disease since the 1990s. The method involves transplanting healthy neural tissue from fetal brains, obtained with consent from women undergoing elective abortions. This tissue is grafted into the patients striatum, typically the worst affected part of the brain. It had been thought that this method offered a good chance of success, since laboratory experiments had shown good levels of behavioural recovery in rodents and non-human primates.

The paper published last week reported the results of the examination of three patients who received transplants ten years before their death. The autopsies investigated why the transplants were not effective for longer, but had some more serious implications for the whole process. While previous studies had noted successful and healthy transplants at 18 months and even up to six years after the procedure, the transplanted tissue at ten years had undergone degeneration and damage similar, and even worse to the host tissue, even though it did not possess the mutant huntingin gene. It is suspected that the severe damage done to the transplant tissue is due to the same toxic environment shared by the host tissue.

Commenting on the study, Dr Freedman said: 'Based on our earlier results we were expecting that the grafts would endure. This tells us we'll have to do a lot of work in the laboratory before going back to the clinic'.

The conclusions drawn from the study are that the risks and mild benefits associated with the tissue graft do not warrant further transplants being carried out at present. The paper also suggests that before this sort of treatment can be successful, lots more work will need to be done on how to control the inflammatory and immune responses in the host tissue.

SOURCES & REFERENCES
PHG Foundation | 24 July 2009
 
Nature News | 20 July 2009
 

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

25 June 2012 - by Holly Rogers 
A single dose of an 'antisense' drug has been shown to slow, or even partially reverse, Huntington's disease in animal studies, according to a study published in Neuron....
04 May 2010 - by Dr Vivienne Raper 
Huntington's Disease affects families as much as individuals; affected parents have a 50 per chance of passing it to their children. This fact makes this book describing the effects of Huntington's on an entire family such a thought-provoking read. And it's funny, chatty and uplifting too...

27 February 2006 - by BioNews 
The latest results from a trial in which five Huntington's disease (HD) patients received fetal nerve tissue transplants show that the treatment can slow, but not stop the progression of the condition. The study, carried out at the Henri Mondor Hospital in France, shows that for some patients, cell transplants...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Moving the Boundaries of Human Reproduction

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Richard Anderson

Dr Sue Avery

Dr Elizabeth Garner

Professor Allan Pacey

Dr Anna Smajdor

Dr Andy Greenfield

Philippa Taylor

Dr César Palacios-González

Fiona Fox

Sarah Norcross

EARLY BIRD DISCOUNT
if you book now


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation